179
He does not stop discussing the use of low-dose aspirin, aspirinetta or baby aspirin, in primary prevention for subjects at cardiovascular risk, therefore potentially more exposed to heart attack or stroke than the general population. To add fuel to the fire the hypothesis of the Task Force of the American Prevention Services according to which between 40 and 59 years it is necessary to weigh well with the doctor whether to start treatment with the drug at low doses, expressly for cardiovascular prevention, in these subjects.
.